and timing for pressure-flow studies [J]. BJU Int, 2001, 88(3):178-182.
[4] Khastgir J, Khan A, Speakman M. Acute urinary retention: medical management and the identification of risk factors for prevention [J]. Nat Clin Pract Urol, 2007, 4(8):422-431.
[5] McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group [J]. N Engl J Med, 1998, 338(9): 557–563.
[6] 华立新,吴宏飞,眭元庚,等.急性尿潴留对血清前列腺特异性抗原的影响[J].中华男科学,2002,8(2):134-135.
[7] McNeal JE. Normal histology of the prostate [J]. Am J Surg Pathol, 1988,12(3):619-623.
[8] 华立新,眭元庚,吴宏飞,等.移行区指数与良性前列腺增生急性尿潴留的关系[J].中华泌尿外科杂志,2001,22(6):366.
[9] Gerstenbluth RE, Steftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of Bcl-2 in areas of inflammation [J]. J Urol, 2002, 167(5):2267-2270.
[10] Mishra VC, Allen DJ, Nicolaou C, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? [J]. BJU Int, 2007, 100(2):327-331.
[11] Wang L, Yang JR, Yang LY,et al. Chronic inflammation in benign prostatic hyperplasia: implications for therapy [J]. Med Hypotheses, 2008, 70(5):1021-1023.
[12] Matsuda T, Fujime M, Suda K. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia [J]. Anal Quant Cytol Histol, 2006, 28(3):121-124.
[13] Shapiro E, Becichs MJ, Hartano V, et al. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostatic hyperplasia [J]. J Urol, 1992, 147(5):1293-1295.
[14] Spiro LH, Labay G, Orkin LA. Prostatic infarction. Role in acute urinary retention [J]. Urology, 1974, 3(3): 345-347.
[15] Tuncel A, Uzun B,
上一页 [1] [2] [3] [4] [5] 下一页